Using procalcitonin to care for hospitalized patients Hospitalist Best Practice J Rush Pierce Jr, MD, MPH Division of Hospital Medicine July 22, 2015.

Slides:



Advertisements
Similar presentations
SEPTICAEMIA Dr. Urvesh V. Shah Associate Professor Editor in Chief, Dept. of Microbiology, GCSMC Journal Of GCS Medical College Medical Sciences.
Advertisements

Horng H Chen MD on behalf of the NHLBI Heart Failure Clinical Research Network Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF):
University of Minnesota – School of Nursing Spring Research Day Glycemic Control of Critically Ill Patients Lynn Jensen, RN; Jessica Swearingen, BCPS,
Survival benefits and policy conflicts in Sepsis
SEPSIS KILLS program Adult Inpatients
Procalcitonin Over the past two decades, the body of literature on the clinical usefulness of procalcitonin (PCT) in adults has grown rapidly. Although.
“Diagnostic value of procalcitonin in well appearing young febrile infants” Pediatrics 2012; 130:
H CAP & H AP Pamela Charity, MD Cathryn Caton, MD, MS.
Correlation of Leukocyte Count with Clinical Outcomes in Hospitalized Patients with Community-Acquired Pneumonia: Results from Rapid Empiric Treatment.
1 Acute Cough Definitions of Lower Respiratory Tract Infections (LRTI), ranging in severity: Acute bronchitis - an acute respiratory tract infection in.
Management of Hepatic Encephalopathy in the Hospital
LSU Journal Club Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections: the ProHOSP Randomized.
Pneumonia Why do we need to know about it? Long recognized as a major cause of death, Pneumonia has been studied intensively since late 1800s. Despite.
Pneumonia & Respiratory Tract Infection: Antibiotic risk for Clostridium difficile Kieran Hand*, Adil Ahmed †, Adriana Basarab ¶, Whitney Chow †, Nick.
Acquired Infections in Long Term Care: Pneumonia WWLHIN Nurse Led Outreach Team Miller Longanilla David Scratch.
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
Serum Procalcitonin Level and Other Biological Markers to Distinguish Between Bacterial and Aseptic Meningitis in Children A European Multicenter Case.
Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled.
July Darius Computer Skills for the Information Age April 13, 2015.
Case - 84 year old woman Main symptoms – Acute dyspnea since 2 weeks, some coughing, yellow sputum Past medical history – Chronic obstructive lung disease.
Antibiotic overuse and misuse in long term care Shira Doron, MD Assistant Professor of Medicine Division of Geographic Medicine and Infectious Diseases.
رب اجعل هذا بلدا آمنا وارزق أهله من الثمرات من امن منهم بالله و اليوم الآخر.
A Service Evaluation of Procalcitonin after PRORATA Daniel Cottle DICM John Butler, Tony Dunne, Sanchia Pickering Manchester Royal Infirmary 2011.
The Importance of Viral Etiology in Hospitalized Patients with Community Acquired Pneumonia in Jefferson County Martin Gnoni MD, Swetha Kadali, MD, Jorge.
Neonates (children less than one month of age) have immature immune systems and are at higher risk for serious complications of bacterial and viral infections,
Karin Schurink Peter Lucas Marc Bonten Stefan Visscher Incorporating Evaluation into the Design of a Decision-Support System UMC Utrecht Radboud University.
Plans for Diagnosis of Community Acquired Pneumonia.
Patient presenting with altered mental status
Shira Doron, MD Assistant Professor of Medicine
Procalcitonin-Guided Antibiotic Therapy
Procalcitonin. Objectives Review current data on procalcitonin Review its use at UCI MC.
Patient # 1 = Lab Results Your Results: –CBC: WBC 22 (normal /ul) –BMP: WNL Urine Pregnancy: Neg Head CT: Neg LP: –Cloudy fluid –Opening pressure:
Role of procalcitonin (PCT) in guiding antibiotic therapy Descriptive review of RCTs using PCT to guide antibiotic therapy –2 RCTs in outpatient primary.
Anemia in the Hospitalized Elderly Hospitalist Best Practice J Rush Pierce Jr, MD, MPH February 29, 2012.
Clinical Approach to the Diagnosis of SARS Joshua P. Metlay, MD, PhD VA Medical Center Division of General Internal Medicine Center for Clinical Epidemiology.
Procalcitonin-Guided Duration of Antimicrobial Therapy in Healthcare-Associated Pneumonia  PCT-guided group with decreased duration of antimicrobial therapy.
Pneumonia Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Introduction Infection involving the.
Is the VIDAS B. R. A. H. M. S PCT assay able to detect a bacterial throat infection? Mr Ajith P George MBChB, MRCS, DO-HNS ENT SpR.
NYU Medical Grand Rounds Clinical Vignette Benjamin Eckhardt, MD PGY-3 October 6, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
SCH Journal Club Use of time from fever onset improves the diagnostic accuracy of C-reactive protein in identifying bacterial infections Wednesday 13 th.
Haemofiltration for sepsis: burial or resurrection?
 Definition An inflammation of lung parenchyma caused by various microorganisms, including bacteria, mycobacteria, fungi and viruses.
Exacerbations. Exacerbations An exacerbation of COPD is an acute event characterized by a worsening of the patient’s respiratory symptoms that is beyond.
Community Acquired Pneumonia (CAP)
United States Statistics on Sepsis
R3 정수웅. Introduction Community-acquired pneumonia − Leading infectious cause of death in developed countries − The mortality in patients with treatment.
Procalcitonin 정량검사의 평가
Towards Global Eminence K Y U N G H E E U N I V E R S I T Y j 내과 R2 이지영.
Community-Acquired Pneumonia Richard G. Wunderink, M.D., and Grant W. Waterer, M.B., B.S., Ph.D. N Engl J Med 2014;370: R3 김선혜 /Prof. 박명재 1.
Antimicrobial Stewardship 2.0 Hospitalist Best Practice Eileen Barrett, MD, MPH, FACP Division of Hospital Medicine UNMH.
Comparison of clinical failure between procalcitonin algorithm-compliant versus procalcitonin algorithm-non-compliant antibiotic prescribing in patients.
Depart. Of Pulmonology and Critical Care Medicine R4 백승숙.
Community Acquired Pneumonia. Definitions Community acquired pneumonia (CAP) – Infection of the lung parenchyma in a person who is not hospitalized or.
Update in Critical Care Medicine Ann Intern Med 2007;147:
Role of Procalcitonin in Managing Adult Patients With Respiratory Tract Infections Philipp Schuetz, MD, MPH; Devendra N. Amin, MD, FCCP; and Jeffrey L.
Time for first antibiotic dose is not predictive for the early clinical failure of moderate–severe community-acquired pneumonia Eur J Clin Microbial Infect.
Etiology of Illness in Patients with Severe Sepsis Admitted to the Hospital from the Emergency Department Alan C. Heffner,1,3 James M. Horton,2 Michael.
Department of Pulmonology 백승숙. Community-acquired pneumonia (CAP) –The most common cause of severe sepsis and the leading cause of death from infection.
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated May 26, 2017.
An AKI project for critically ill cancer patients
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated August 30, 2017.
Daizo Tanaka, MD; Shinya Unai, MD; Harrison T. Pitcher, MD
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated August 30, 2017.
Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Pneumonia and COPD Exacerbations Derek N. Bremmer, PharmD, BCPS March 10,
Biomarker-Driven Management of Sepsis and Antibiotics Evidence and Perspectives.
Treating Vasodilatory Shock in the ICU
COPD Exacerbation (1) C.L.I.P.S.
Ordering Sputum Cultures in Community Acquired Pneumonia
Community Acquired Pneumonia
Presentation transcript:

Using procalcitonin to care for hospitalized patients Hospitalist Best Practice J Rush Pierce Jr, MD, MPH Division of Hospital Medicine July 22, 2015

Roadmap for today Illustrative cases Procalcitonin: what it is and why it might work Evidence for usefulness of procalcitonin in settings of specific interest to hospitalists Availability and cost Use of Procalcitonin – possible clinical algorithms Discussion with specialists and experts 07/24/2014 Using procalcitonin to care for hospitalized patients 2

Disclosures Financial: none Biases: – Evidence should inform our thinking – Local variation is an interesting part of life – Medicine is fun 07/24/2014 Using procalcitonin to care for hospitalized patients 3

Case 1 64 y/o man with DM, HTN, HFpEF admitted with 1 wk of increased SOB, cough, gray sputum and chills. Exam: T = 37.5, JVD, rales at right base and trace edema. WBC = 13,000, BNP = 800. CXR shows “peribronchial cuffing & reticular opacities could represent developing pneumonia vs. interstitial edema, clinical correlation advised” 07/24/20144 Using procalcitonin to care for hospitalized patients

Clinical questions 1.Does this patient have a respiratory infection, CHF or both? 2.Should I order antibiotics on admission? 3.Should he go home on antibiotics? 07/24/20145 Using procalcitonin to care for hospitalized patients

Case 2 83 y/o woman with dementia at SNF recovering from hip fx, adm to MICU looking dry with BP = 80, acute delirium and AKI. WBC = 14,000, lactate = 4.5, 35 WBC’s in urine on admission and CXR with right lower lobe opacities c/w atelectasis vs possible aspiration. Put on Unasyn and vanc, volume resuscitated. Blood, urine cultures neg, CXR about same, now being transferred to floor. 07/24/20146 Using procalcitonin to care for hospitalized patients

Clinical questions 1.Did this patient have severe sepsis due to an infection, or delirium precipitated by volume depletion without infection? 2.Should I continue antibiotics now? 3.Should she go back to the SNF on antibiotics? 07/24/20147 Using procalcitonin to care for hospitalized patients

Procalcitonin: what it is and why it might work 07/24/2014 Using procalcitonin to care for hospitalized patients 8

Procalcitonin Calcitonin – a hormone seeking a job – Produced by parafollicular cells in thyroid – Opposes effect of PTH, inhibits osteoclasts, stimulates osteoblasts – No known pathologic state associated with deficiency Procalcitonin – precursor molecule processed by parafollicular cells to calcitonin – Undetectable in normal state 07/24/2014 Using procalcitonin to care for hospitalized patients 9

Calcitonin 07/24/2014 Using procalcitonin to care for hospitalized patients 10 Source: Muller B: Swiss Med Wkly 2001:131:595

Procalcitonin in sepsis Rises dramatically with bacterial infections, but very little with viral infections Rarely rises in sepsis due to non-infectious origin Peak levels correlates with prognosis Levels fall when bacterial infection treated Not affected by immune suppression Half-life 25 – 30 hours 07/24/2014 Using procalcitonin to care for hospitalized patients 11

Procalcitonin and sepsis prognosis 07/24/2014 Using procalcitonin to care for hospitalized patients 12 Source: Jensen J: Crit Care Med 2006;34:2596

Why procalcitonin might be useful Diagnosis of infection is often difficult – Clinical tools have significant limitations – Specific etiology often elusive (sepsis <50%, CAP <30%) Antimicrobial use has its downsides – Key driver to antibiotic resistance – Can be associated with adverse reactions – Major risk factor for C difficele – Often costly 07/24/2014 Using procalcitonin to care for hospitalized patients 13

Evidence for usefulness of procalcitonin in settings of specific interest to hospitalists 07/24/2014 Using procalcitonin to care for hospitalized patients 14

ProHOSP Trial Prospective randomized controlled trial; 6 ED’s in Switzerland, pts presenting with possible LRTI (CAP, bronchitis, exacerbation of COPD) Initiation and continuation of antibiotic based on clinician judgment vs PCT algorithm IN PCT algorithm arm, clinician could overrule for specific indication 07/24/2014 Using procalcitonin to care for hospitalized patients 15 Source: Schuetz P: JAMA 2009;302:1059

07/24/2014 Using procalcitonin to care for hospitalized patients 16 Source: Schuetz P: JAMA 2009;302:1059

07/24/2014 Using procalcitonin to care for hospitalized patients 17 Source: Schuetz P: JAMA 2009;302:1059

07/24/2014 Using procalcitonin to care for hospitalized patients 18 Source: Schuetz P: JAMA 2009;302:1059

ProHOSP Trial - conclusions In patients with LRTIs, a strategy of PCT guidance compared with standard guidelines resulted in – similar rates of adverse outcomes, as well as – lower rates of antibiotic exposure – lower rates of antibiotic-associated adverse effects. 07/24/2014 Using procalcitonin to care for hospitalized patients 19 Source: Schuetz P: JAMA 2009;302:1059

PRORATA Trial Prospective randomized controlled trial; 5 ICU’s in France, pts adm to ICU with suspected sepsis Initiation and continuation of antibiotic based on clinician judgment vs PCT algorithm IN PCT algorithm arm, clinician could overrule for specific indication 07/24/2014 Using procalcitonin to care for hospitalized patients 20 Source: Bouadma L: Lancet 2010;375:463

07/24/2014 Using procalcitonin to care for hospitalized patients 21 Source: Bouadma L: Lancet 2010;375:463

07/24/2014 Using procalcitonin to care for hospitalized patients 22

07/24/2014 Using procalcitonin to care for hospitalized patients 23 Source: Bouadma L: Lancet 2010;375:463

PRORATA Trial - Conclusions A procalcitonin-guided strategy to treat suspected bacterial infections in non-surgical patients in intensive care units could reduce antibiotic exposure and selective pressure with no apparent adverse outcomes. 07/24/2014 Using procalcitonin to care for hospitalized patients 24 Source: Bouadma L: Lancet 2010;375:463

BACH Trial International multicenter cohort study, patients presenting to ED with dyspnea and acute heart failure (AHF) was diagnostic consideration Signs, sxs, lab, markers including PCT 30, 60, 90 day mortality 07/24/2014 Using procalcitonin to care for hospitalized patients 25 Source: Maisal A: European J Heart Failure 2012;14, 278

07/24/2014 Using procalcitonin to care for hospitalized patients 26 Source: Maisal A: European J Heart Failure 2012;14, 278

BACH Trial - Conclusions Procalcitonin may aid in the diagnosis of pneumonia, particularly in cases with high diagnostic uncertainty. PCT may aid in the decision to administer antibiotic therapy to patients presenting with AHF in which clinical uncertainty exists regarding a superimposed bacterial infection. 07/24/2014 Using procalcitonin to care for hospitalized patients 27 Source: Maisal A: European J Heart Failure 2012;14, 278

Meta-analysis of PCT use 07/24/2014 Using procalcitonin to care for hospitalized patients 28 Source: Schuetz P: Arch Intern Med 2011;171:1322

07/24/2014 Using procalcitonin to care for hospitalized patients 29 Source: Schuetz P: Arch Intern Med 2011;171:1322

Case 1 64 y/o man with DM, HTN, HFpEF admitted with 1 wk of increased SOB, cough, gray sputum and chills. Exam: T = 37.5, JVD, rales at right base and trace edema. WBC = 13,000, BNP = 800. CXR shows “peribronchial cuffing & reticular opacities could represent developing pneumonia vs. interstitial edema, clinical correlation advised” 07/24/ Using procalcitonin to care for hospitalized patients

Clinical questions 1.Does this patient have a respiratory infection, CHF or both? 2.Should I order antibiotics on admission? 3.Should he go home on antibiotics? 07/24/ Using procalcitonin to care for hospitalized patients

Case 2 83 y/o woman with dementia at SNF recovering from hip fx, adm to MICU looking dry with BP = 80, acute delirium and AKI. WBC = 14,000, lactate = 4.5, 35 WBC’s in urine on admission and CXR with right lower lobe opacities c/w atelectasis vs possible aspiration. Put on Unasyn and vanc, volume resuscitated. Blood, urine cultures neg, CXR about same, now being transferred to floor. 07/24/ Using procalcitonin to care for hospitalized patients

Clinical questions 1.Did this patient have severe sepsis due to an infection, or delirium precipitated by volume depletion without infection? 2.Should I continue antibiotics now? 3.Should she go back to the SNF on antibiotics? 07/24/ Using procalcitonin to care for hospitalized patients

Availability and cost of procalcitonin at UNMH Currently sent out to ARUP Reference Lab – FedEx afternoons Mon – Fri to ARUP, run next day, reported within 24 hrs – 3 to 5 day turnaround Charge = $ /24/2014 Using procalcitonin to care for hospitalized patients 34

Use of Procalcitonin – possible clinical algorithms 07/24/2014 Using procalcitonin to care for hospitalized patients 35

07/24/2014 Using procalcitonin to care for hospitalized patients 36 Source: Schuetz P: BMC Medicine 2011;9:107

07/24/2014 Using procalcitonin to care for hospitalized patients 37 Source: Schuetz P: BMC Medicine 2011;9:107

Discussion with specialists and experts Should we advocate for POC PCT testing? Should we use PCT to guide initiation and continuation of antibiotic therapy for: – LRTI – Pts coming out of ICU on antibiotics Should we teach use of PCT to learners? 07/24/2014 Using procalcitonin to care for hospitalized patients 38